Clinical Trials Sponsored by Gedea Biotech AB

Total 54 results

Gedea Biotech AB

Completed

Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis (EpHect)

Vulvovaginal Candidiasis

Sweden
Gedea Biotech AB

Completed

Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis (Nefertiti)

Bacterial Vaginosis

United Kingdom, Sweden
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis

Bacterial Vaginosis

Sweden
Gedea Biotech AB

Recruiting

A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group (Nefertiti 2)

Bacterial Vaginosis

Sweden
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Sweden
Gedea Biotech AB

Completed

VVC Sampling Study for Analysis Validation

Vulvovaginal Candidiasis

United Kingdom
Bohus Biotech AB

Completed

A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF) (Decorate01)

Correction of Nasolabial Folds

Sweden
Active Biotech AB

Completed

ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

Romania, Russian Federation, United Kingdom, Ukraine, Bulgaria
Active Biotech AB

Completed

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Denmark, Sweden
Active Biotech AB

Completed

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Renal Cell Carcinoma | Pancreatic Cancer | Non-Small-Cell Lung Carcinoma

United States, Norway, United Kingdom
Galecto Biotech AB

Completed

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Safety and Tolerability

United Kingdom
Active Biotech AB

Completed

ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Denmark, Russian Federation
Galecto Biotech AB

Completed

RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Active Biotech AB

Active, not recruiting

A Study of Laquinimod Eye-drops in Healthy Participants

Eye Diseases

Austria
Active Biotech AB

Completed

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Prostate Cancer

United States, Canada, Sweden
Active Biotech AB

Completed

A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

Prostate Cancer

France, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
Active Biotech AB

Completed

An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)

Systemic Sclerosis

Germany, Sweden, Switzerland
Active Biotech AB

Completed

A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

Healthy

Sweden
Galecto Biotech AB
Covance

Withdrawn

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Non-alcoholic Steatohepatitis (NASH)
AB Biotek

Completed

Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine

Immunologic Deficiency Syndromes | Covid19 | Vaccine Reaction | Influenza | Immunity | Cytokine Storm

Spain
Galecto Biotech AB
Comac Medical

Active, not recruiting

A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Hepatic Impairment

Bulgaria
AB Biotics, SA

Completed

Prospective Study to Determine the Factors Influencing Infant Colic

Infant Colic

Mexico, Spain
AB Biotics, SA

Terminated

Effect of Probiotics on Recurrent Urinary Tract Infections (CYSCARE)

Urinary Tract Infections

Spain
AB Biotics, SA

Terminated

Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

Irritable Bowel Syndrome | Small Intestinal Bacterial Overgrowth

Spain
AB Biotics, SA

Completed

Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination (FLUVAC21)

Influenza Vaccine

Spain
AB Biotics, SA

Completed

Observational Prospective Study With Probiotic Supplementation on Infants With FGDI

Functional Gastrointestinal Disorders | Infantile Colic | Functional Constipation

Italy
AB Biotics, SA

Terminated

Combined Nutritional Therapies for the Treatment of Ulcerative Colitis

Colitis, Ulcerative

Spain
AB Biotics, SA

Completed

Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients

Depressive Disorder, Major

Spain
AB Biotics, SA

Completed

A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia

Moderate Hypercholesterolemia

France
Galecto Biotech AB
OPIS s.r.l

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

Myelofibrosis

Germany, Italy, United States, Australia
AB Biotics, SA

Completed

Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners (AB-ULTRA)

Signs and Symptoms

Spain
AB Biotics, SA

Completed

Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers

Healthy

Spain
AB Biotics, SA

Completed

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Non Alcoholic Fatty Liver

Mexico
AB Biotics, SA

Completed

Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota

Vaginal Infection

Spain
University of Pennsylvania
Active Biotech AB

Recruiting

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Multiple Myeloma

United States
Galecto Biotech AB
QPS Holdings LLC

Completed

A Study to Compare Pharmacokinetics of GB1211

Pharmacokinetics

Netherlands
Galecto Biotech AB
Syneos Health; bioRASI, LLC

Completed

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

United States, Spain, Israel, France, United Kingdom, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
M.D. Anderson Cancer Center
Active Biotech AB

Not yet recruiting

Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-Essential Thrombocytosis Myelofibrosis

United States
Roswell Park Cancer Institute
Active Biotech AB

Completed

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate Cancer

United States
AB Biotics, SA
University of Extremadura

Completed

Combination of AB-LIFE Probiotic Plus Monacolin K to Reduce Blood Cholesterol

Hypercholesterolemia
Galecto Biotech AB
Hoffmann-La Roche; Linical Europe GmbH

Active, not recruiting

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Non-Small Cell Lung Cancer

Spain, Poland, France
AB Biotics, SA
Hospital Clinic of Barcelona

Completed

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Bipolar Disorder

Spain
AB Biotics, SA
Hospital de Nens de Barcelona

Completed

Probiotic Intervention After Surgical Removal of Mandibular Third Molars

Surgery--Complications | Molar, Third

Spain
AB Biotics, SA
Clínica Odontológica Nart en Barcelona

Completed

Study of Colonization of Strains L.Plantarum and L.Brevis in the Product AB-DENTALAC Chewing Gum (AB-GUM-2016)

Periodontal Disease
AB Biotics, SA
Germans Trias i Pujol Hospital

Completed

Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic (RECOVER)

HIV | Premature Aging

Spain
Centros de Investigación de Nutrición y Salud
AB Biotek

Completed

Fibromyalgia Treatment With Enzyme DAO

Fibromyalgia

Spain
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Galecto Biotech... and other collaborators

Recruiting

GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma

United States
AB Biotics, SA
Hospital General Dr. Manuel Gea González; Innovacion y Desarrollo de Estrategias...

Terminated

Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections

Tonsillitis | Pharyngitis | Upper Respiratory Tract Infections

Mexico
Biotest
Accovion GmbH; ICON plc; SYNLAB Analytics and Services Germany GmbH; Phoenix Clinical... and other collaborators

Completed

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Congenital Afibrinogenemia | Congenital Hypofibrinogenemia

Bulgaria, Egypt, Germany, Lebanon, Tunisia
AB Biotics, SA
Centre for the Development of Industrial Technology, Ministry of Science...

Recruiting

Effect of Probiotics on Infant's Fecal Microbiota Composition (BABYCARE)

Microbial Colonization

Spain

Clinical Trials Sponsored by Gedea Biotech AB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations